Adenoviral gene transfer of erythropoietin confers cytoprotection to isolated pancreatic islets

Abstract

Overexpression of EPO protects islets from destruction and does not compromise islet function. Genetic engineering with EPO may be a viable approach for improving islet survival and engraftment in the transplant setting, but regulation of the gene's expression will be an important prerequisite to this strategy.